China Tiotropium Bromide Market Survey Report, 2016-2020 & 2021-2025 – ResearchAndMarkets.com

0

DUBLIN–(BUSINESS WIRE)–The “Chinese Tiotropium Bromide Market Investigation Report 2021-2025” report has been added to from ResearchAndMarkets.com offer.

Tiotropium bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006.

In 2017, tiotropium bromide inhalation powder was included in the National Health Insurance Catalog. In the first half of 2021, in addition to Boehringer Ingelheim International GmbH, there are Nanchang Hongyi Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Zhejiang Xianju Pharmaceutical Co., Ltd. in tiotropium bromide in China. market.

According to the market research, the sales of tiotropium bromide in the Chinese market increased from 2016 to 2019. Especially after tiotropium bromide inhalation powder was included in the national medical insurance catalog in 2017, its sales increased steadily from 2017 to 2019.

However, its sales fell 19.3% year-on-year to 274 million yuan in 2020. The main reason for its sales decline is that the COVID-19 outbreak impacted the overall business. hospital diagnosis and treatment. The CAGR of tiotropium bromide in the Chinese market from 2016 to 2020 is 4.73%.

The analyst predicts that with the effective easing of the COVID-19 epidemic, the sales volume of tiotropium bromide in the Chinese market from 2021 to 2025 will experience restorative growth, promoting the increase in sales.

By the end of 2020, the number of chronic resistant disease patients in China had risen to over 100 million. Hence, the sales of tiotropium bromide will continue to grow, supporting the growth of the tiotropium bromide market.

Topics Covered:

  • The impact of COVID-19 on the Chinese tiotropium bromide market

  • China Tiotropium Bromide Sales Value 2016-2020

  • Competitive Landscape of China Tiotropium Bromide Market

  • tiotropium bromide price in china

  • China Tiotropium Bromide Price by Regions and Manufacturers

  • Analysis of factors affecting the development of the Chinese tiotropium bromide market

  • China Tiotropium Bromide Market Outlook 2021 to 2025

Main topics covered:

1 Relevant concepts of tiotropium bromide

1.1 Indications for tiotropium bromide

1.2 Tiotropium Bromide Development in China

1.3 Government Approval of Tiotropium Bromide in China

1.4 The impact of COVID-19 on China Tiotropium Bromide Sales

2 China Tiotropium Bromide Sales, 2016-2020

2.1 Tiotropium Bromide Sales Value

2.1.1 Overall sales value

2.1.2 Sales Value by Region

2.2 Tiotropium Bromide Sales Volume

2.2.1 Overall Sales Volume

2.2.2 Sales Volume by Region

2.3 China Tiotropium Bromide Sales by Dosage Form, 2016-2020

2.3.1 Gas (powder) Aerosol

2.3.2 Power of inhalation

3 Analysis of Tiotropium Bromide Key Manufacturers in China, 2016-2020

3.1 Tiotropium Bromide Major Manufacturers Market Share Analysis

3.1.1 Market Share Survey by Sales Value

3.1.2 Market Share Survey by Sales Volume

3.2 Boehringer Ingelheim International GmbH

3.2.1 Company Profile

3.2.2 SPIRIVA (Boehringer Ingelheim International GmbH’s Tiotropium Bromide) Sales in China

3.3 Nanchang Hongyi Pharmaceutical Co., Ltd.

3.3.1 Company Profile

3.3.2 Hongmingrui (Nanchang Hongyi Pharmaceutical Co., Ltd. Tiotropium Bromide) Sales in China

3.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

3.4.1 Company Profile

3.4.2 China Tianqingsule (Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Tiotropium Bromide) Sales

3.5 Zhejiang Xianju Pharmaceutical Co., Ltd.

3.5.1 Business Profile

3.5.2 China Biduoyi (Zhejiang Xianju Pharmaceutical Co., Ltd. Tiotropium Bromide) Sales

4 Tiotropium Bromide Price for Different Manufacturers in China, 2020-2021

4.1 Boehringer Ingelheim International GmbH (SPIRIVA)

4.2 Nanchang Hongyi Pharmaceutical Co., Ltd. (Hongmingrui)

4.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Tianqingsule)

4.4 Zhejiang Xianju Pharmaceutical Co., Ltd. (Biduoyi)

5 China Tiotropium Bromide Market Outlook, 2021- 2025

5.1 Influencing Factors of China Tiotropium Bromide Market Development

5.1.1 The impact of COVID-19 on the Chinese tiotropium bromide market

5.1.2 Market Drivers and Opportunities

5.1.3 Market Threats and Challenges

5.2 Market Size Forecast

5.3 Market Trend Forecast

Companies cited

  • Boehringer Ingelheim International GmbH

  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  • Nanchang Hongyi Pharmaceutical Co.,Ltd

  • Zhejiang Xianju Pharmaceutical Co.,Ltd

For more information on this report, visit https://www.researchandmarkets.com/r/sb77mt

Share.

Comments are closed.